Inflation Eats Savings The 38 Interest Rate Threshold to Preserve Purchasing Power Yardeni Warns Fed May Need to Raise Rates in July to Appease Bond Vigilantes Health Care Sector ETFs Show Signs of Recovery Offering Potential Portfolio Defense Ryman Healthcare Shares See Uptick Amid Market Optimism EasyJet Reports Wider FirstHalf Losses as Iran Conflict Drives Fuel Costs Higher and Weakens Demand Lidl Surpasses Morrisons to Become UKs FifthLargest Grocer as Discount Grocery Momentum Builds My Size Inc MYSZ Q4 2025 Earnings Large EPS Miss Overshadowed by Modest Stock Gain Richardson Electronics Q1 2026 Earnings Earnings Beat Lifts Shares Despite Revenue Uncertainty ADXN Q1 2024 Earnings EPS Reported at 1227 No Revenue as DevelopmentStage Biotech Continues ORGO Q1 2026 Earnings Notable EPS Miss Amidst Challenging Quarter Loews Corporation Q1 2026 Earnings Steady EPS Delivery Amid Mixed Market Sentiment AGRO Q1 2026 Earnings Significant EPS Miss Amid Challenging Agricultural Conditions Hercules Capital 625 Notes HCXY Edge Higher Amid Stable Credit Conditions Global Interactive Technologies GITS Faces Sharp Pullback Tests Key Support at 152 Inspired Entertainment INSE Climbs 369 as Volume Picks Up Key Levels in Focus Shuttle Pharmaceuticals SHPH Declines 493 as Investors Eye Key Support at 055 Eve Holding Inc EVEX Edges Higher as Shares Test Key Resistance at 32 Investors Warn of BoomandBust Cycle in Memory Stocks Amid AI Frenzy HLX Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds Duolingo Inc DUOL Edges Higher as Stock Consolidates Near Key Levels VLYPN Q1 2026 Earnings Preferred Stock EPS Beats Estimates by 507 Impinj PI Q1 2026 Earnings Mixed Quarter as EPS Slightly Misses Expectations Yet Stock Gains MGE Energy Q1 2026 Earnings EPS Beat Driven by Operational Strength CIMP Q1 2026 Earnings EPS Surpasses Estimates as Company Demonstrates Resilient Performance FSBC Q1 2026 Earnings EPS Beats Expectations Despite Flat Stock Reaction BlackRock BLK Q1 2026 Earnings EPS Surges Past Estimates Stock Gains on Strong Core Business OCUL Q1 2026 Earnings EPS Misses Estimates as PreCommercial Biotech Continues Development